OptiNose, Inc.
USD9.60
+0.00 (+0.00%)
CEO
Ramy A. Mahmoud
IPO Date
2017-10-13
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$9.60
Prev. Close
$9.60
Day Low
$9.60
Day High
$9.60
52W Low
$4.82
52W High
$20.02
Market Cap
$0.10B
Volume
0.81M
| -61.1 |
| 31 Dec 2022 | FY | 87.9% | -98.1% | 132.2% | -51.9% | -2.32 | 0.79 | -2.1 |
| 31 Dec 2021 | FY | 87.7% | -109.4% | 375.0% | -49.2% | -6.00 | 2.71 | -16.9 |
| 31 Dec 2020 | FY | 84.7% | -200.2% | -1448.6% | -52.1% | 19.37 | 3.46 | -30.5 |
| 31 Dec 2019 | FY | 84.7% | -314.6% | -176.9% | -63.1% | 1.21 | 4.65 | -53.2 |
| 31 Dec 2018 | FY | 77.5% | -1509.7% | -89.9% | -49.2% | 0.61 | 8.28 | -34.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -31.7% | -20.3% | 0.47 | 15.89 | -194.1 |
| 31 Dec 2016 | FY | 100.0% | 47.6% | -589.2% | 54.4% | -3.97 | 6.88 | 34.3 |
| 31 Dec 2015 | FY | 100.0% | -33310.6% | 104.3% | -176.9% | -0.53 | 2.20 | -268.9 |
| -54.0 |
| 30 Sept 2024 | Q3 | 89.9% | 2.3% | -1.1% | 0.4% | -3.09 | 0.79 | 62.5 |
| 30 Jun 2024 | Q2 | 90.3% | -37.0% | 17.7% | -5.7% | -2.98 | 3.94 | -5.1 |
| 31 Mar 2024 | Q1 | 91.2% | -94.5% | 14.2% | -16.8% | -1.32 | 2.48 | -43.2 |
| 31 Dec 2023 | Q4 | 88.7% | -50.2% | 11.5% | -9.3% | -1.52 | 0.60 | -54.5 |
| 30 Sept 2023 | Q3 | 88.8% | -46.9% | 12.0% | -9.2% | -1.69 | 0.60 | -55.7 |
| 30 Jun 2023 | Q2 | 86.8% | 13.5% | -3.8% | 2.5% | -1.88 | 0.63 | 196.7 |
| 31 Mar 2023 | Q1 | 85.6% | -157.5% | 25.3% | -16.2% | -1.77 | 0.67 | -43.4 |
| 31 Dec 2022 | Q4 | 85.7% | -72.6% | 26.8% | -10.5% | -2.32 | 0.79 | -43.5 |